Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 3,000 shares at $4.28 ($13K) on 2014-12-31, disclosed to the SEC on 2015-01-02.
Open-market purchase of $13k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.26 | 1,500 | $6K | 49.9% |
| 2 | $4.28 | 1,500 | $6K | 50.1% |
| Total | $4.27 avg | 3,000 | $13K | 100% |
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2014-07-02 | $13K | — | Filing → |